Congenital malformation of the eye with glaucoma as a major feature Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Feb 2012

Mitosol: FDA approved

An adjunct to ab externo glaucoma surgery.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Mitosol

Glaukos Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Mitosol

(mitomycin-C)Orphan drug

Glaukos Corporation

12.1 Mechanism of Action Mitosol ® inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree ...

Approved Feb 2012FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Congenital malformation of the eye with glaucoma as a major feature.
Search all trials →

Search clinical trials for Congenital malformation of the eye with glaucoma as a major feature →

Recent News & Research

No recent news articles indexed yet for Congenital malformation of the eye with glaucoma as a major feature.
Search PubMed for Congenital malformation of the eye with glaucoma as a major feature →

Browse all Congenital malformation of the eye with glaucoma as a major feature news →

Specialist Network

No specialists currently listed for Congenital malformation of the eye with glaucoma as a major feature.

View all Congenital malformation of the eye with glaucoma as a major feature specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰